Search - tctmd.com

Displaying 41 - 60 of 170

Sort: Relevancy | Date

Treatment Gaps Abound in Heart Failure but Can Be Closed, Studies Show

Michael O'Riordan

May 21, 2024

News Daily News

New HCM Guidelines Focus on Cardiac Myosin Inhibitors and Exercise

Yael L. Maxwell

May 08, 2024

News Daily News

TAVI Outcomes Linked to LV Recovery in Patients With Severe Dysfunction

Michael O'Riordan

May 06, 2024

News Opinion CV Team Dispatch

May 2024 Dispatch for the CV Team

L.A. McKeown

May 01, 2024

News Opinion Off Script

Evoque and Patisiran: A Tale of Two Regulatory Journeys

Sanjay Kaul, MD

March 29, 2024

News Conference News ACC 2024

Most HFrEF Patients Eligible for Quadruple Therapy, but Few Get It

Michael O'Riordan

March 27, 2024

News Daily News

ACC Updates HFrEF Decision Pathway, Reinforcing the Four Pillars of Therapy

Todd Neale

March 11, 2024

News Conference News THT 2024

Debating the Role of T-TEER in the Sickest Patients

Michael O'Riordan

March 05, 2024

News Daily News

New Risk Score Better for Capturing Medical Urgency for Heart Transplantation

Michael O'Riordan

February 19, 2024

News Daily News

GDMT Rates Low in HFrEF, Particularly in Women

L.A. McKeown

January 30, 2024

News Daily News

AHA Selects 2023’s Leading Cardiovascular Research

Todd Neale

December 22, 2023

News Daily News

Daily Texts Boost Self-care in HFrEF but Don’t Impact Outcomes

L.A. McKeown

December 08, 2023

News Opinion CV Team Dispatch

November 2023 News Roundup

L.A. McKeown

November 01, 2023

News Conference News HFSA 2023

STRONG-HF Analysis: Safety Events Common but Manageable in GDMT Optimization

L.A. McKeown

October 18, 2023

News Conference News HFSA 2023

Survey Offers Clues to Waning Appeal of Acute HF/Transplant Fellowships

Shelley Wood

October 13, 2023

News Daily News

FDA Decides Not to Approve Patisiran in ATTR Cardiomyopathy

L.A. McKeown

October 10, 2023

News Opinion CV Team Dispatch

October 2023 News Roundup

L.A. McKeown

October 01, 2023

News Daily News

Prescribing a Generic for CVD? Plan, Drug Type, and Condition Impact Availability

Todd Neale

September 13, 2023

News Conference News ESC 2023

ESC Focused Update on HF Synthesizes New Trial Data for Practical Use

L.A. McKeown

September 01, 2023

News Opinion CV Team Dispatch

September 2023 News Roundup

L.A. McKeown

September 01, 2023

Advertisement

Treatment Gaps Abound in Heart Failure but Can Be Closed, Studies Show

New HCM Guidelines Focus on Cardiac Myosin Inhibitors and Exercise

TAVI Outcomes Linked to LV Recovery in Patients With Severe Dysfunction

May 2024 Dispatch for the CV Team

Evoque and Patisiran: A Tale of Two Regulatory Journeys

Most HFrEF Patients Eligible for Quadruple Therapy, but Few Get It

ACC Updates HFrEF Decision Pathway, Reinforcing the Four Pillars of Therapy

Debating the Role of T-TEER in the Sickest Patients

New Risk Score Better for Capturing Medical Urgency for Heart Transplantation

GDMT Rates Low in HFrEF, Particularly in Women

AHA Selects 2023’s Leading Cardiovascular Research

Daily Texts Boost Self-care in HFrEF but Don’t Impact Outcomes

November 2023 News Roundup

STRONG-HF Analysis: Safety Events Common but Manageable in GDMT Optimization

Survey Offers Clues to Waning Appeal of Acute HF/Transplant Fellowships

FDA Decides Not to Approve Patisiran in ATTR Cardiomyopathy

October 2023 News Roundup

Prescribing a Generic for CVD? Plan, Drug Type, and Condition Impact Availability

ESC Focused Update on HF Synthesizes New Trial Data for Practical Use

September 2023 News Roundup

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content